
For most patients, asthma can be effectively managed using inhaled medications. However, patients with severe and uncontrolled asthma or who experience exacerbations may require systemic corticosteroids (SCSs) to maintain asthma control. Clinical and real‐world data from studies investigating asthma severity, control and treatment practices around the globe have suggested that SCS are overused in asthma management, adding to the already substantial healthcare burden experienced by patients. Coordinated changes at the patient, provider, institutional and policy levels, such as increased disease awareness, promoting better adherence to treatment guidelines and increasing availability of safe and effective alternatives to SCS, are likely necessary to reduce the SCS burden for patients with asthma in Asia.
Like
Save
Share